Detalhe da pesquisa
1.
Everolimus Plus Exemestane in Advanced Breast Cancer: Safety Results of the BALLET Study on Patients Previously Treated Without and with Chemotherapy in the Metastatic Setting.
Oncologist
; 22(6): 648-654, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28432226
2.
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: a population-based study.
J Transl Med
; 14(1): 292, 2016 10 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-27737711
3.
Genome-wide association study of susceptibility loci for breast cancer in Sardinian population.
BMC Cancer
; 15: 383, 2015 May 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-25956309
4.
Author Correction: Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Sci Rep
; 10(1): 1918, 2020 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32005869
5.
Long-term outcomes in stage IIIB breast cancer patients who achieved less than a pathological complete response (
Oncologist
; 14(11): 1051-60, 2009 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-19897535
6.
Sex-Related Differences in Impact on Safety of Pharmacogenetic Profile for Colon Cancer Patients Treated with FOLFOX-4 or XELOX Adjuvant Chemotherapy.
Sci Rep
; 9(1): 11527, 2019 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31395900
7.
Predictive factors for 6 vs 12 cycles of Folfiri-Bevacizumab in metastatic colorectal cancer.
Oncotarget
; 9(2): 2876-2886, 2018 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29416820
8.
Dose-dense primary chemotherapy, as part of multidisciplinary treatment, for inoperable stage III B breast cancer--long-term results of a phase II trial.
Oncology
; 72(1-2): 17-26, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17998786
9.
Meeting psychosocial and health information needs to ensure quality of cancer care in outpatients.
Eur J Oncol Nurs
; 29: 98-105, 2017 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-28720273
10.
Prognostic role of KRAS mutations in Sardinian patients with colorectal carcinoma.
Oncol Lett
; 12(2): 1415-1421, 2016 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-27446446
11.
Thyroid Dysfunction in Patients with Metastatic Carcinoma Treated with Sunitinib: Is Thyroid Autoimmunity Involved?
Thyroid
; 25(11): 1255-61, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26414109
12.
Triple-negative breast cancer frequency and type of BRCA mutation: Clues from Sardinia.
Oncol Lett
; 7(4): 948-952, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24944648
13.
Genetic markers for toxicity of adjuvant oxaliplatin and fluoropyrimidines in the phase III TOSCA trial in high-risk colon cancer patients.
Sci Rep
; 4: 6828, 2014 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25370899
14.
Undescribed case of necrotic ulcerative amyopathic dermatomyositis in bone metastatic breast cancer.
Breast J
; 14(6): 591-2, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-19000050
15.
Jejunal obstruction caused by metastasis from an undiagnosed breast cancer: a case report.
Tumori
; 98(3): 89e-91e, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22825527
16.
Hypothyroidism and Thyroid Autoimmunity as a Prognostic Biomarker of Better Response in Metastatic Cancer Long-Term Survivors Treated with Sunitinib.
Thyroid
; 26(9): 1336-7, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27267354
17.
Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience.
Clin Colorectal Cancer
; 10(1): 42-7, 2011 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21609935
18.
Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review.
Tumori
; 97(6): 690-2, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22322832
19.
Inflammatory breast cancer in Italy: epidemiological and clinical aspects.
Cancer
; 116(11 Suppl): 2736-40, 2010 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20503402
20.
Long-term maintenance of prognostic value of survivin and its relationship with p53 in T4 breast cancer patients.
Exp Ther Med
; 1(1): 59-64, 2010 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23136593